A global scientific strategy to cure hepatitis B

Members of the ICE-HBV Working Groups, ICE-HBV Stakeholders Group Chairs, ICE-HBV Senior Advisors, Peter A. Revill, Francis V. Chisari, Joan M. Block, Maura Dandri, Adam J. Gehring, Haitao Guo, Jianming Hu, Anna Kramvis, Pietro Lampertico, Harry L.A. Janssen, Massimo Levrero, Wenhui Li, T. Jake Liang, Seng Gee Lim, Fengmin Lu, M. Capucine Penicaud, John E. TavisRobert Thimme, Patrick Arbuthnot, Andre Boonstra, Kyong Mi Chang, Per Jei Chen, Dieter Glebe, Luca G. Guidotti, Jacques Fellay, Carlo Ferrari, Louis Jansen, Daryl T.Y. Lau, Anna S. Lok, Mala K. Maini, William Mason, Gail Matthews, Dimitrios Paraskevis, Jörg Petersen, Barbara Rehermann, Eui Cheol Shin, Alex Thompson, Florian van Bömmel, Fu Sheng Wang, Koichi Watashi, Hung Chih Yang, Zhenghong Yuan, Man Fung Yuen, Timothy Block, Veronica Miller, Ulrike Protzer, Christian Bréchot, Stephen Locarnini, Marion G. Peters, Raymond F. Schinazi

Research output: Contribution to journalComment/debate

Abstract

Chronic hepatitis B virus (HBV) infection is a global public health challenge on the same scale as tuberculosis, HIV, and malaria. The International Coalition to Eliminate HBV (ICE-HBV) is a coalition of experts dedicated to accelerating the discovery of a cure for chronic hepatitis B. Following extensive consultation with more than 50 scientists from across the globe, as well as key stakeholders including people affected by HBV, we have identified gaps in our current knowledge and new strategies and tools that are required to achieve HBV cure. We believe that research must focus on the discovery of interventional strategies that will permanently reduce the number of productively infected cells or permanently silence the covalently closed circular DNA in those cells, and that will stimulate HBV-specific host immune responses which mimic spontaneous resolution of HBV infection. There is also a pressing need for the establishment of repositories of standardised HBV reagents and protocols that can be accessed by all HBV researchers throughout the world. The HBV cure research agenda outlined in this position paper will contribute markedly to the goal of eliminating HBV infection worldwide.

Original languageEnglish
Pages (from-to)545-558
Number of pages14
JournalThe Lancet Gastroenterology and Hepatology
Volume4
Issue number7
DOIs
Publication statusPublished - Jul 1 2019

    Fingerprint

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Members of the ICE-HBV Working Groups, ICE-HBV Stakeholders Group Chairs, ICE-HBV Senior Advisors, Revill, P. A., Chisari, F. V., Block, J. M., Dandri, M., Gehring, A. J., Guo, H., Hu, J., Kramvis, A., Lampertico, P., Janssen, H. L. A., Levrero, M., Li, W., Liang, T. J., Lim, S. G., Lu, F., Penicaud, M. C., ... Schinazi, R. F. (2019). A global scientific strategy to cure hepatitis B. The Lancet Gastroenterology and Hepatology, 4(7), 545-558. https://doi.org/10.1016/S2468-1253(19)30119-0